Congenital heart defects and skeletal malformations syndrome: genes and variants
Explore variant evidence for Congenital heart defects and skeletal malformations syndrome across 1 analyzed protein (ABL1). Linked ClinVar records include 14 pathogenic or likely pathogenic variants, 12 variants of uncertain significance and 4 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Congenital heart defects and skeletal malformations syndrome
ABL1: Tyrosine-protein kinase ABL1
It coordinates cytoskeletal remodeling, adhesion, DNA-damage responses, and growth signaling through tightly regulated tyrosine phosphorylation. Fusion with BCR removes normal control and creates the constitutively active kinase that drives chronic myeloid leukemia and subsets of acute lymphoblastic leukemia.
14 ClinVar pathogenic / likely pathogenic and 16 uncertain variants in ABL1 have source records linked to Congenital heart defects and skeletal malformations syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Congenital heart defects and skeletal malformations syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ABL1 W99R | 99 | SH3 | Pathogenic / likely pathogenic (★★) |
| ABL1 V506A | 506 | Pathogenic / likely pathogenic (★★) | |
| ABL1 V506M | 506 | Pathogenic / likely pathogenic (★★) | |
| ABL1 A433T | 433 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| ABL1 G254R | 254 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| ABL1 E509K | 509 | Pathogenic / likely pathogenic (★★) | |
| ABL1 Y226C | 226 | Pathogenic / likely pathogenic (★★) | |
| ABL1 P230L | 230 | Pathogenic / likely pathogenic (★★) | |
| ABL1 D363A | 363 | Protein kinase | Pathogenic / likely pathogenic (★) |
| ABL1 D504G | 504 | Pathogenic / likely pathogenic (★) | |
| ABL1 E292V | 292 | Protein kinase | Pathogenic / likely pathogenic (★) |
| ABL1 W48S | 48 | CAP | Pathogenic / likely pathogenic (★) |
| ABL1 P784L | 784 | Pathogenic / likely pathogenic (★) | |
| ABL1 G511R | 511 | Pathogenic / likely pathogenic |
Which prediction tools work for Congenital heart defects and skeletal malformations syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- VARITY: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 95 out of 100
- EVE: 93 out of 100
- ESM1b (LLR): 93 out of 100
- phyloP: 93 out of 100
- CADD: 93 out of 100
- MetaSVM: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 83 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 82 out of 100
- phastCons: 75 out of 100
- MutPred: 73 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Leukemia, Philadelphia chromosome-positive, resistant to imatinib also has ClinVar records linked to ABL1 variants; they fall partly in the same places as the Congenital heart defects and skeletal malformations syndrome variants (5 pathogenic / likely pathogenic).
- Chronic myeloid leukemia also has ClinVar records linked to ABL1 variants; they fall mostly in different places as the Congenital heart defects and skeletal malformations syndrome variants (3 pathogenic / likely pathogenic).
Diseases related to Congenital heart defects and skeletal malformations syndrome
- Gastrointestinal stromal tumor, also linked to ABL1
- Colorectal cancer, also linked to ABL1
- Heart disease, also linked to ABL1
- Microcephaly, also linked to ABL1
- Acute lymphoid leukemia, also linked to ABL1
- Leukemia, Philadelphia chromosome-positive, resistant to imatinib, also linked to ABL1
- Lip and oral cavity carcinoma, also linked to ABL1
- Chronic myeloid leukemia, also linked to ABL1
Frequently asked questions
Which genes have records linked to Congenital heart defects and skeletal malformations syndrome?
This view contains 1 analyzed proteins: ABL1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 14 pathogenic or likely pathogenic variants, 12 variants of uncertain significance and 4 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 35 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center